Actualités sur Science
- plus
Almac Discovery and Debiopharm International SA Announce a Licensing Agreement for the Development of a Novel Wee-1 Inhibitor
Craigavon, N.I., UK, Lausanne, Switzerland (ots) - Almac Discovery (www.almacgroup.com/discovery), a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, and Debiopharm International SA (Debiopharm - www.debiopharm.com), a Switzerland based specialty ...
plusDebiopharm International SA Announces Results from Phase I Dose-Escalation Study of Debio 1347/CH5183284
Lausanne, Switzerland (ots) - Debio 1347/CH5183284 was evaluated in patients with FGFR genomically activated advanced solid tumors Debiopharm International SA (Debiopharm - www.debiopharm.com), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company, today announced the results from the phase I ...
plusGenePOC announces product launch in Europe and Middle East
Québec, Canada/Lausanne, Switzerland (ots) - GenePOC announces the commercialization of its Clostridium difficile and Group B Strep molecular tests in Europe, along with onboarding additional partners to cover the EMEA market GenePOC, Inc. (GenePOC) a member of the Debiopharm Group is proud to announce that it has started the commercialization of its first two CE-IVD marked tests, GenePOC(TM) CDiff and GenePOC(TM) GBS ...
plusGrünenthal receives Breakthrough Therapy Designation from U.S. FDA for neridronic acid for the treatment of CRPS
Aachen / Pisa (ots) - Grünenthal receives Breakthrough Therapy Designation from U.S. FDA for neridronic acid for the treatment of complex regional pain syndrome (CRPS), a debilitating orphan disease with high medical need - Neridronic acid is the first investigational medicine to receive Breakthrough Therapy ...
plusImmunoQure AG announces publication in Cell of naturally occurring patient-derived autoantibodies that limit human diseases
Düsseldorf (ots) - ImmunoQure AG, a German biotechnology company focused on the development of autoantibodies as therapeutics to treat common human diseases today announced the publication of data in the leading scientific journal Cell, demonstrating that such therapeutics can limit a variety of common human ...
plusBioMed X - Merck collaboration in the field of selective kinase inhibitors reaches major milestone
Heidelberg (ots) - BioMed X Innovation Center and Merck announced today that their collaboration, under which Merck has acquired all generated research and development results in the field of selective kinase inhibitors from BioMed X, has reached a major milestone. In addition, the respective research group at BioMed X is now offering a unique set of bio- and ...
plusMerck and Biocartis to Collaborate on New Liquid Biopsy Technology for RAS Biomarker Testing
Darmstadt, Germany (ots/PRNewswire) - - Merck becomes first pharmaceutical company to collaborate with multiple diagnostic providers to support RAS biomarker testing - Collaboration allows Merck to provide complementary molecular testing solutions to various laboratory segments - Biocartis' fully automated Idylla(TM) system will enable more clinics to assess RAS ...
plusSaxoTraderGO Introduces Touch ID Support
Copenhagen (ots/PRNewswire) - Saxo Bank bolsters mobile trading offering Saxo Bank, the online trading and investment specialist, has enabled client identification on SaxoTraderGO through biometric verification. This application update for iPhones and iPads containing Touch ID support has been released to Saxo Bank clients and is now globally available. As an optional feature, the update is capable of storing multiple ...
plusBoehringer Ingelheim and BioMed X extend collaboration to discover novel therapeutic concepts for the treatment of psychiatric diseases
Heidelberg (ots) - The BioMed X Innovation Center announced today that they have extended their current collaboration with Boehringer Ingelheim in the field of chronic obstructive pulmonary disease (COPD) to establish a second team of outstanding scientists from around the world to discover novel therapeutic ...
plusBoehringer Ingelheim and BioMed X apply crowdsourcing to establish a team of scientists for identifying key epigenetic regulators of COPD
Ingelheim and Heidelberg (ots) - - Aims to identify of novel epigenetic drivers to find new approaches for treating COPD - Crowdsourcing used to find unconventional solutions and identify the best talent from around the world - New research team will be established at the BioMed X Innovation Center in Heidelberg, ...
plusBrainlab Introduces New Generation of VMAT* for Brain and Spine at 3rd ESTRO in Barcelona
Munich (ots) - Introduction of new "Elements" completes the portfolio of automated, indication-specific planning tools for radiosurgery/SBRT The "Elements" strategy-indication-specific focused software applications aimed at enhancing the workflow for difficult to treat indications in the brain and spine introduced in 2013-comes full circle with the introduction of ...
plusNew possibilities in the fight against pancreatic cancer
Zug, Switzerland (ots) - Licence extension in the contract between AmVac and the Helmholtz Centre for the adjuvant Malp-2 offers sustainable potential for patients, attending physicians and for pharmaceutical and medical research. Milestone thanks to licence extension The licence for Malp-2 was successfully extended in November 2014. The adjuvant can now be used for the first time for all preventive and therapeutic ...
plusGottlieb Duttweiler Institute GDI
Tim Berners-Lee awarded the Gottlieb Duttweiler Prize 2015
Zurich (ots) - The 12th Gottlieb Duttweiler Prize has been awarded to Britain's Sir Timothy Berners-Lee, who invented the World Wide Web twenty-five years ago. The Swiss Gottlieb Duttweiler Institute (GDI) is honouring Sir Tim for his pioneering invention. He will be presented with the distinguished prize on 29 April 2015. Earlier prizewinners include Jimmy Wales, Kofi A. Annan and Václav Havel. Sir Tim developed the ...
plusEuropean Society for Medical Oncology (ESMO)
ESMO announces annual medical oncology congress platform in Europe from 2016
Lugano, Switzerland (ots) - The European Society for Medical Oncology, the pan-European association representing medical oncologists in Europe and beyond, has announced that it will be organising an annual Congress in Europe from 2016. A record 19,809 participants from 134 countries gathered at ESMO 2014 in Madrid to hear the results of trials which included ...
plusZiehm Imaging at EuroSpine 2014 / Lunch symposium: Controversies in intraoperative spinal imaging
Nuremberg, Germany (ots) - At this year's EuroSpine Congress in Lyon, innovation leader Ziehm Imaging invites international experts to share their clinical experience in spinal neurosurgery orthopedic and traumatology. During a lunch symposium on October 1st Christoph Josten (University Hospital Leipzig), Christian Raftopoulos (Brussels Saint-Luc University Hospital) ...
plus$300,000 Grant to be Awarded to Winning Proposal on "Neurodegeneration: Perceptual Consequences and Quantification in Human Subjects" / The Hearing Industry Research Consortium (IRC) issues 2014 Grant
Singapore (ots) - Since 2012 the hearing industry's largest manufacturers have collaborated to sponsor a non-competitive, mutually agreed upon research agenda benefitting the hearing aid industry, its customers, and end users. The framework for this collaboration is the Hearing Industry Research Consortium (IRC). ...
plusA young researcher from Italy wins this year's "Basel Declaration Award for Education in Animal Research" (Picture)
plusHPI Research School offers ten new scholarships to young scientists
Potsdam (ots) - Hasso Plattner Institute (HPI) has announced that it will be offering scholarships to ten new researchers at its international Research School. Beginning in the upcoming winter semester, the young researchers will be joining the current 25-member team at the Potsdam Research School. Qualified candidates, who are planning a PhD or who already hold one, may submit their application until August 15th to the ...
plusPreclinical Data Support the Potential of AmVacs RSV Vaccine / Innovative approach to the prevention of severe respiratory infections
Zug (ots) - AmVac AG has announced that it has made decisive progress in the development of their new RSV vaccine. The vaccine candidate is based on AmVac's innovative Sendai virus vector platform and developed for the prevention of respiratory infections, which are induced by RSV (respiratory syncytial virus). RSV ...
plusYoung researcher from Greece is the winner of this year's "Basel Declaration Award for Education in Animal Research"
plusEuropean Renal Association - European Dialysis and Transplant Association (ERA-EDTA)
XLVIII ERA-EDTA Congress in Prague from 23 June to 26 June 2011
Prag (ots) - The congress of the ERA-EDTA (European Renal Association and European Dialysis and Transplant Association) is the biggest congress in Europe on nephrology and renal replacement therapy. You are cordially invited to attend this Congress. The Opening Press Conference will be held on Thursday 23rd June, 11 am (Corinthia Hotel). Topic: Can the high level of cardiovascular risk among the European population be ...
plusUniversität Zürich / University Zurich
University of Zurich: Denmark, Finland and Belgium have best democracies
Zurich (ots) - - Indication: PDF-File can be downloaded free of charge under: http://www.presseportal.ch/de/pm/100020780/?langid=2 - A new democracy barometer from the University of Zurich and the Social Science Research Center Berlin (WZB) shows the development of the thirty best ...
Un documentplusMars hosts key scientific panel discussion at one of the largest ever gatherings of Nobel Laureates
Lindau, Germany (ots) - To tackle the world's most pressing issues, genuine collaboration between the academic community, government and industry is needed, Mars, Incorporated said yesterday. As part of the Lindau Nobel Laureate Meetings, Mars hosted an interdisciplinary panel discussion addressing the far-reaching impact science can have on society. The ...
plusAmVac AG registers progress with the RSV vaccine
Zug (ots) - The Swiss AmVac AG, a biopharmaceutical company located in Zug, has made significant advances in the manufacture and production of its vaccine candidate against RSV over the last few months. This vaccine candidate is based on the new Sendai vector technology for which Max-Planck-Innovations GmbH has acquired the exclusive licence. This technology, which has been developed by Prof. Wolfgang Neubert's ...
plusInnovation boost to tackle Climate Change
Budapest, Hungary (ots) - While Heads of State are negotiating to reach a substantial climate agreement in Copenhagen, the EU is stepping forward to take the lead in developing innovations to tackle climate change. The European Institute of Innovation and Technology (EIT) has launched a groundbreaking new research, innovation and education initiative that aims to answer the various challenges of climate change. A ...
plusSupporting innovative pain research / EFIC-Grunenthal Grant 2009 awarded to five young scientists
Aachen, Germany (ots) - The European Federation of Chapters of the International Association for the Study of pain (EFIC) and the pharmaceutical company Grunenthal awarded the EFIC-Grunenthal Grant to five young European scientists. The grant will provide financial support for their future projects in ...
plusEuropean AutoID Award 2009 honors Object Security Surveillance Solution
Zurich (ots) - Silverstroke AG, an Ettlingen/Germany-based communications solution provider, won this year's European AutoID Award in the category "RFID". In doing so, the awarding committee acknowledged a groundbreaking object surveillance solution which uses RFID to protect an art collection. The winning project was realized by Silverstroke in collaboration ...
plusHumboldt Forum for Food and Agriculture
Humboldt Forum for Food and Agriculture: The World Faces Dire Food Shortages
Berlin (ots) - - Problem Likely to Expand to Developed Countries - Agricultural Productivity Growth Declining - Governments and Businesses Need to Urgently Invest in Agriculture In response to the threat of global malnutrition and food insecurity, the recently established Humboldt Forum for Food and Agriculture has urged the immediate adoption ...
plusHumboldt Forum for Food and Agriculture
International Press Conference: "The World Faces Dire Food Shortages"
An Invitation to the Launch of Food First Zurich (ots) - An Urgent Call to Action by The Humboldt Forum for Food and Agriculture International Press Conference (incl. telephone conference, audio webcast) 16 April 2009, 3 PM CET Hotel Maritim proArte Friedrichstrasse 151 Berlin, Germany In response to the growing threat of ...
plus